Global and regional estimates for COPD prevalence: Systematic review and meta-analysis

Background The burden of chronic obstructive pulmonary disease (COPD) across many world regions is high. We aim to estimate COPD prevalence and number of disease cases for the years 1990 and 2010 across world regions based on the best available evidence in publicly accessible scientific databases. Methods We conducted a systematic search of Medline, EMBASE and Global Health for original, population–based studies providing spirometry– based prevalence rates of COPD across the world from January 1990 to December 2014. Random effects meta–analysis was conducted on extracted crude prevalence rates of COPD, with overall summaries of the meta–estimates (and confidence intervals) reported separately for World Health Organization (WHO) regions, the World Bank's income categories and settings (urban and rural). We developed a meta–regression epidemiological model that we used to estimate the prevalence of COPD in people aged 30 years or more. Findings Our search returned 37 472 publications. A total of 123 studies based on a spirometry–defined prevalence were retained for the review. From the meta–regression epidemiological model, we estimated about 227.3 million COPD cases in the year 1990 among people aged 30 years or more, corresponding to a global prevalence of 10.7% (95% confidence interval (CI) 7.3%–14.0%) in this age group. The number of COPD cases increased to 384 million in 2010, with a global prevalence of 11.7% (8.4%–15.0%). This increase of 68.9% was mainly driven by global demographic changes. Across WHO regions, the highest prevalence was estimated in the Americas (13.3% in 1990 and 15.2% in 2010), and the lowest in South East Asia (7.9% in 1990 and 9.7% in 2010). The percentage increase in COPD cases between 1990 and 2010 was the highest in the Eastern Mediterranean region (118.7%), followed by the African region (102.1%), while the European region recorded the lowest increase (22.5%). In 1990, we estimated about 120.9 million COPD cases among urban dwellers (prevalence of 13.2%) and 106.3 million cases among rural dwellers (prevalence of 8.8%). In 2010, there were more than 230 million COPD cases among urban dwellers (prevalence of 13.6%) and 153.7 million among rural dwellers (prevalence of 9.7%). The overall prevalence in men aged 30 years or more was 14.3% (95% CI 13.3%–15.3%) compared to 7.6% (95% CI 7.0%– 8.2%) in women. Conclusions Our findings suggest a high and growing prevalence of COPD, both globally and regionally. There is a paucity of studies in Africa, South East Asia and the Eastern Mediterranean region. There is a need for governments, policy makers and international organizations to consider strengthening collaborations to address COPD globall

Trends in COPD mortality and hospitalizations in countries and regions of Asia-Pacific

10.1111/j.1440-1843.2008.01415.xRespirology14190-97RSPI

Lung function testing in health and disease: Issues pertaining to Asia-Pacific populations

The Asia-Pacific region comprise of diverse ethnic populations and healthcare systems of highly variable developmental stages. We face challenges in lung function testing, many of which are different from the issues encountered in the west. In some places, access to proper lung function testing facilities is very limited due to resource constraints or geographic inconvenience. It is important to note the potential differences of normative values in Asia-Pacific populations, compared with established values derived from populations of Caucasian ethnicity, hence the need to choose from available prediction formulae the ones that most closely approximate the subjects being tested. The criteria for defining abnormality is a hot topic globally. In the Asia-Pacific region, the trade-off between simplicity and thus ease of application and the pitfall of under- or over-diagnosis based on fixed cut-off values has to be recognized. The promotion of wider availability and proper utilization of lung function testing will go a long way in the enhancement of respiratory health and disease management in the region. © 2011 Asian Pacific Society of Respirology.link_to_OA_fulltex